222 related articles for article (PubMed ID: 25068025)
1. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines.
Vasti C; Hertig CM
World J Cardiol; 2014 Jul; 6(7):653-62. PubMed ID: 25068025
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies.
Miano C; Romaniello D; Mazzeschi M; Morselli A; Da Pra S; Sacchi F; Bongiovanni C; Sgarzi M; Pantano E; Lauriola M; D'Uva G
Front Oncol; 2022; 12():831105. PubMed ID: 35664762
[TBL] [Abstract][Full Text] [Related]
3. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.
Schneider JW; Chang AY; Rocco TP
Semin Oncol; 2001 Oct; 28(5 Suppl 16):18-26. PubMed ID: 11706392
[TBL] [Abstract][Full Text] [Related]
5. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
6. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity.
Sawyer DB; Zuppinger C; Miller TA; Eppenberger HM; Suter TM
Circulation; 2002 Apr; 105(13):1551-4. PubMed ID: 11927521
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab cardiotoxicity: Speculations regarding pathophysiology and targets for further study.
Schneider JW; Chang AY; Garratt A
Semin Oncol; 2002 Jun; 29(3 Suppl 11):22-8. PubMed ID: 12138394
[TBL] [Abstract][Full Text] [Related]
8. Expression and Localization of Neuregulin-1 (Nrg1) and ErbB2/ErbB4 Receptors in Main Endocrine Organs of the Rhesus Monkey.
Zhao WJ
Int J Endocrinol Metab; 2013; 11(3):162-6. PubMed ID: 24348587
[TBL] [Abstract][Full Text] [Related]
9. Essential roles of Her2/erbB2 in cardiac development and function.
Negro A; Brar BK; Lee KF
Recent Prog Horm Res; 2004; 59():1-12. PubMed ID: 14749494
[TBL] [Abstract][Full Text] [Related]
10. ErbB2 is essential in the prevention of dilated cardiomyopathy.
Crone SA; Zhao YY; Fan L; Gu Y; Minamisawa S; Liu Y; Peterson KL; Chen J; Kahn R; Condorelli G; Ross J; Chien KR; Lee KF
Nat Med; 2002 May; 8(5):459-65. PubMed ID: 11984589
[TBL] [Abstract][Full Text] [Related]
11. IgG-Containing Isoforms of Neuregulin-1 Are Dispensable for Cardiac Trabeculation in Zebrafish.
Samsa LA; Ito CE; Brown DR; Qian L; Liu J
PLoS One; 2016; 11(11):e0166734. PubMed ID: 27846271
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy.
Gui C; Zhu L; Hu M; Lei L; Long Q
Cardiovasc Pathol; 2012; 21(5):414-20. PubMed ID: 22285193
[TBL] [Abstract][Full Text] [Related]
13. [Neuregulin1/ErbB system: importance in the control of cardiovascular function].
Lopes-Conceição L; Dias-Neto M; Fontes-Sousa AP; Mendes-Ferreira P; Maia-Rocha C; Henriques-Coelho T; de Keulenaer G; Leite Moreira AF; Brás-Silva C
Acta Med Port; 2011 Dec; 24 Suppl 4():1009-20. PubMed ID: 22863512
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of an ErbB3- and ErbB4-specific ligand screening system, and a screen of neuregulin-1 mutants].
Qi Y; Wei DZ; Liu XF; Zhou MD
Yi Chuan; 2010 Dec; 32(12):1247-55. PubMed ID: 21513150
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
[TBL] [Abstract][Full Text] [Related]
16. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
17. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy.
Ozcelik C; Erdmann B; Pilz B; Wettschureck N; Britsch S; Hübner N; Chien KR; Birchmeier C; Garratt AN
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8880-5. PubMed ID: 12072561
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of calcitriol enhanced neuregulin-1/ErbB signaling in rat myocardium.
Dang R; Guo Y; Zhu Y; Yang R; Cai H; Jiang P
Pharmazie; 2016 Apr; 71(4):192-5. PubMed ID: 27209698
[TBL] [Abstract][Full Text] [Related]
19. The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.
Wadugu B; Kühn B
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2139-47. PubMed ID: 22427524
[TBL] [Abstract][Full Text] [Related]
20. ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer.
Mill CP; Zordan MD; Rothenberg SM; Settleman J; Leary JF; Riese DJ
Genes Cancer; 2011 Aug; 2(8):792-804. PubMed ID: 22393464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
